Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Abilify was produced by Otsuka and Bristol-Myers Squibb.

FDA starts review of Lundbeck’s antipsychotic aripiprazole

A marketing application in Europe is not expected until 2013. Otsuka originally developed aripiprazole and sells a once-daily tablet formulation under the Abilify brand name in collaboration with Bristol-Myers ... Otsuka estimates that Abilify will

Dr Véronique Walsh joins BMS UK

Dr Véronique Walsh. Dr Walsh will lead the sales and marketing teams for BMS' neuroscience and immunoscience portfolio which includes Orencia (abatacept), Abilify (aripiprazole) and Perfalgan (paracetamol IV), as well as

NICE recommends aripiprazole

NICE's FAD recommends the use of Bristol-Myers Squibb's atypical anti-psychotic drug Abilify (aripiprazole) as an option for the treatment of adolescent schizophrenia. ... The National Institute for Health and Clinical Excellence's (NICE) Final Appraisal

Breathing easier

France. Influenza A virus H1N1 vaccine. Panvax H1N1 (CSL Biotherapies)  . Influenza A virus H1N1 subtype . US. Zolpidem oral spray. Zolpimist (NovaDel)  . Insomnia . US. Aripiprazole . Abilify (Bristol-Myers Squibb). Behavioural disorders

People, March, 2010

She will be leading the Abilify and Sustiva accounts for BMS and Caelyx for Schering-Plough.

[ Previous 5 results ] 9 10 11 12 13 14 15 16 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...